Gene · 7732
Papers1,998
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,998
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retraction Note: RNA editing of BFP, a point mutant of GFP, using artificial APOBEC1 deaminase to restore the genetic code. | Sci Rep | 2025 | 39934491 | PubTator, text mining | PubMed |
| Multiplex generation and single-cell analysis of structural variants in mammalian genomes. | Science | 2025 | 39883753 | PubTator, text mining | PubMed |
| Artificial cells with all-aqueous droplet-in-droplet structures for spatially separated transcription and translation. | Nat Commun | 2025 | 39856089 | PubTator, text mining | PubMed |
| Occurrence of virulence genes in multidrug-resistant Escherichia coli isolates from humans, animals, and the environment: One health perspective. | PLoS One | 2025 | 39854442 | PubTator, text mining | PubMed |
| Effects of Physical Activity Level, Strength, Balance, and Body Composition on Perceived Health in Healthy Adults. | Sports (Basel) | 2025 | 39852615 | PubTator, text mining | PubMed |
| The novel CD16A/anti-CD3 bifunctional protein, eCD16A/anti-CD3-BFP, redirects T cell cytotoxicity toward antibody-bound target cells. | Hum Vaccin Immunother | 2025 | 39763374 | PubTator, text mining | PubMed |
| RNF112, whose transcription is regulated by KLF4, inhibits colorectal cancer growth via promoting ubiquitin-dependent degradation of NAA40. | Cell Biol Toxicol | 2025 | 39757327 | PubTator, text mining | PubMed |
| The vectors went in two-by-two: Transduction efficiency and tolerability of dual and triple rAAV vector delivery following intravitreal injection for genome-editing applications. | Exp Eye Res | 2025 | 39710097 | PubTator, text mining | PubMed |
| Imaging of endogenous RNA in live cells using sequence-activated fluorescent RNA probes. | Nucleic Acids Res | 2025 | 39657756 | PubTator, text mining | PubMed |
| Dual pH-responsive CRISPR/Cas9 ribonucleoprotein xenopeptide complexes for genome editing. | Eur J Pharm Sci | 2025 | 39647515 | PubTator, text mining | PubMed |
| A benchmarked, high-efficiency prime editing platform for multiplexed dropout screening. | Nat Methods | 2025 | 39562753 | PubTator, text mining | PubMed |
| Genome scale CRISPR screens identify actin capping proteins as key modulators of therapeutic responses to radiation and immunotherapy. | bioRxiv | 2025 | 38293095 | PubTator, text mining | PubMed |
| FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapy. | bioRxiv | 2025 | 37205599 | PubTator, text mining | PubMed |
| Long-Term Dentin Bonding Performance of Universal Adhesives: The Effect of HEMA Content and Bioactive Resin Composite. | J Funct Biomater | 2024 | 39728179 | PubTator, text mining | PubMed |
| A synthetic protein-level neural network in mammalian cells. | Science | 2024 | 39666795 | PubTator, text mining | PubMed |
| Protocol for iterative enrichment of integrated sgRNAs via derivative CRISPR-Cas9 libraries from genomic DNA of sorted fixed cells. | STAR Protoc | 2024 | 39661507 | PubTator, text mining | PubMed |
| Reversing protonation of weakly basic drugs greatly enhances intracellular diffusion and decreases lysosomal sequestration. | Elife | 2024 | 39641975 | PubTator, text mining | PubMed |
| Methodology for Studying Hypothalamic Regulation of Feeding Behaviors. | Methods Protoc | 2024 | 39584979 | PubTator, text mining | PubMed |
| Control of spatio-temporal patterning via cell growth in a multicellular synthetic gene circuit. | Nat Commun | 2024 | 39562554 | PubTator, text mining | PubMed |
| A modular platform for bioluminescent RNA tracking. | Nat Commun | 2024 | 39557883 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7732/papers?page=5